The repair device grasps the mitral leaflets and brings them closer together, reducing the space through which blood can flow backward. This changes valve function at the leaflet level rather than replacing the valve. When regurgitation decreases, a greater proportion of ventricular blood can move forward, which may improve cardiac output and lessen symptoms related to inefficient circulation.
Echocardiography provides real-time guidance for positioning the repair device and confirming that the mitral leaflets have been appropriately grasped and approximated. It also helps clinicians assess the immediate reduction in backward blood flow. This imaging-based feedback supports procedural decisions while the device is being placed and helps determine whether the intended valve-function improvement has been achieved.
Percutaneous mitral repair may be considered for selected patients with either degenerative or functional mitral regurgitation. These categories describe different clinical settings for valve dysfunction, so the underlying cause helps frame patient selection and treatment planning. The approach is especially relevant when significant regurgitation is present and conventional surgery carries elevated risk.
Clinicians introduce the catheter through the venous system and advance it to the heart. The catheter then crosses the interatrial septum to reach the mitral valve, allowing the repair device to be directed toward the leaflets. This transcatheter route avoids open-heart access while providing a pathway for leaflet grasping, approximation, and immediate assessment.
The approach is intended for selected patients with significant mitral regurgitation, particularly those who face elevated risk from surgical treatment. Patient assessment also considers whether the regurgitation is degenerative or functional. In this context, the procedure offers a less invasive treatment option for improving valve function when open-heart surgery may present substantial concerns.
Immediate assessment focuses on whether the device has reduced backward blood flow through the mitral valve and improved its function. Clinicians can also relate the procedural result to expected physiological benefits, including better forward cardiac output and potential relief of breathlessness. These findings help determine the early effectiveness of repair in the treated patient.